Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma

Fig. 5

Clinical verification of HCC samples. Statistical analysis between CTCs of HCC patients and EpCAM-IML (a), Vimentin-IML (b) and GPC3-IML (c) focusing on the time that before and after the operation. d The total captured numbers of cells by IMLs were analyzed on the time that before and after the operation. The captured CTC of patient No. 5 (e) and patient No. 15 (f) by the seven immunoliposomes before and after treatment

Back to article page
\